(Q39624214)

13 September 2017

1 reference

title

The role of hormones in the etiology of human breast cancer (English)

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

13 September 2017

1 reference

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

20 March 2023

author name string

M. A. Kirschner

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A326377

20 March 2023

language of work or name

English

0 references

publication date

1 June 1977

1 reference

full work available at URL

13 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

20 March 2023

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

20 March 2023

1 reference

13 September 2017

volume

39

1 reference

13 September 2017

issue

6 Suppl

1 reference

13 September 2017

page(s)

2716-2726

1 reference

Testosterone and Androstenedione Blood Production Rates in Normal Women and Women with Idiopathic Hirsutism or Polycystic Ovaries*

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197706%2939%3A6%3C2716%3A%3AAID-CNCR2820390659%3E3.0.CO%3B2-3

Plasma prolactin in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197706%2939%3A6%3C2716%3A%3AAID-CNCR2820390659%3E3.0.CO%3B2-3

THYROID HORMONE AS A PROPHYLACTIC AGENT FOLLOWING RADICAL TREATMENT OF BREAST CANCER

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197706%2939%3A6%3C2716%3A%3AAID-CNCR2820390659%3E3.0.CO%3B2-3

Thyroid Function in Relation to Mammary Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197706%2939%3A6%3C2716%3A%3AAID-CNCR2820390659%3E3.0.CO%3B2-3

Thyroid activity in relation to prognosis in mammary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197706%2939%3A6%3C2716%3A%3AAID-CNCR2820390659%3E3.0.CO%3B2-3

Prolonged estrogen therapy in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197706%2939%3A6%3C2716%3A%3AAID-CNCR2820390659%3E3.0.CO%3B2-3

Urinary steroid values as a guide to prognosis in breast cancer

21 January 2018

1

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

The pill, estrogens, and the breast.Epidemiologic aspects

20 March 2023

2

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Retrospective study of the association between use of rauwolfia derivatives and breast cancer in English women

20 March 2023

4

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

SOME FEATURES OF BREAST CANCER AND THYROID DEFICIENCY. REPORT OF 280 CASES.

20 March 2023

5

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Competition between estradiol and estriol for end organ receptor proteins

20 March 2023

11

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Oophorectomy in breast cancer; an attempt to correlate clinical results with oestrogen production

20 March 2023

13

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Abnormal urinary steroid excretion and subsequent breast cancer. A prospective study in the Island of Guernsey

20 March 2023

14

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Selection of breast-cancer patients for adrenalectomy or hypophysectomy by determination of urinary 17-hydroxycorticosteroids and aetiocholanolone

20 March 2023

15

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Abnormal excretion of urinary steroids by women with early breast cancer

20 March 2023

17

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

The Effects of Long-Term Estrogen Administration to Women following Hysterectomy

20 March 2023

18

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Levels of serum protein-bound iodine in patients with metastatic carcinoma of the breast

20 March 2023

19

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

20 March 2023

20

31

1051

Cassell

1971

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Oestrogen fractions during early reproductive life in the aetiology of breast cancer

20 March 2023

21

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

20 March 2023

22

35

970

Costlow

1975

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

20 March 2023

23

35

3351

Waard

1975

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Oestriol in human breast tumours

20 March 2023

24

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Estrogen profiles of Oriental and Caucasian women in Hawaii

20 March 2023

25

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Thyroid function in patients with mammary cancer

20 March 2023

26

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Oral Contraceptives as Related to Cancer and Benign Lesions of the Breast 2

20 March 2023

28

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

20 March 2023

29

6

18

1976

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Influence of thyroid hormone on estrogen metabolism in man.

20 March 2023

32

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

EFFECT OF THYROID ON HYDROXYLATION OF ESTROGEN IN MAN

20 March 2023

33

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

The Metabolic Clearance and Blood Production Rates of Estriol in Normal, Non-Pregnant Women

20 March 2023

34

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Prolactin concentrations in patients with breast cancer.

20 March 2023

35

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Prolactin receptors: characteristics of the particulate fraction binding activity.

20 March 2023

36

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

THE PREMENSTRUAL ENDOMETRIAL PATTERN OF WOMEN WITH BREAST CANCER. A STUDY OF PROGESTATIONAL ACTIVITY

20 March 2023

37

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Source of Estrogen Production in Postmenopausal Women1

20 March 2023

38

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Reserpine use in relation to breast cancer

20 March 2023

42

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

THYROID-ANDROGEN INTERRELATIONS AND THE HYPOCHOLESTEREMIC EFFECT OF ANDROSTERONE*

20 March 2023

43

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Peripheral Metabolism of3H-estradiol and the Excretion of Endogenous Estrone and Estriol Glucosiduronate in Women with Breast Cancer

20 March 2023

44

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Elevated serum levels of estrogen and prolactin in daughters of patients with breast cancer

20 March 2023

45

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Menopausal Estrogens and Breast Cancer

20 March 2023

47

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

THE RELATIONSHIP OF BREAST DISEASE TO THYROID DISEASE

20 March 2023

49

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Breast cancer in patients with Hashimoto's thyroiditis

20 March 2023

52

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Androgen production and metabolism in normal and virilized women

20 March 2023

55

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

The production, origin and role of dehydroepiandrosterone and delta 5-androstenediol as androgen prehormones in hirsute women

20 March 2023

57

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Urinary 17-ketosteroid excretion of women with advanced breast cancer

20 March 2023

58

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Letter: Breast cancer and Hashimoto thyroiditis

20 March 2023

59

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Plasma-prolactin in human breast cancer.

20 March 2023

60

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Matched-pairs study of reserpine use and breast cancer

20 March 2023

61

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Endocrine influences on human mammary cancer formation. A critique

20 March 2023

64

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Cancer and thyroid function

20 March 2023

67

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Estrogen profiles and breast cancer

20 March 2023

69

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Metabolic clearance and blood production rates of estrogens in postmenopausal women

20 March 2023

71

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Reserpine and Breast Cancer in a Retirement Community

20 March 2023

76

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Etiology of Human Breast Cancer: A Review2

20 March 2023

77

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Urine oestrogen profiles of Asian and North American women

20 March 2023

78

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

II. URINARY EXCRETION OF ESTRONE, ESTRADIOL, AND ESTRIOL BY PATIENTS WITH BREAST CANCER AND BENIGN BREAST DISEASE

20 March 2023

79

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Alternative discriminating function for determining hormone dependency of breast cancer.

20 March 2023

84

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Hypothalamic-pituitary-thyroid axis in breast cancer.

20 March 2023

87

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Hypothalamic-pituitary-prolactin axis in breast cancer

20 March 2023

88

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Thyroid function in breast cancer

20 March 2023

90

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Suppression by ergocornine and iproniazid of carcinogen-induced mammary tumors in rats; effects on serum and pituitary prolactin levels.

20 March 2023

91

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

THE EXCRETION OF OESTRONE, PREGNANEDIOL AND PREGNANETRIOL IN BREAST CANCER PATIENTS. II. EFFECT OF OVARIECTOMY, OVARIAN IRRADIATION AND CORTICOSTEROIDS

20 March 2023

92

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

20 March 2023

93

35

766

Noble

1975

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Letter: Rauwolfia derivatives and breast cancer

20 March 2023

94

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Oral Contraceptives and Reduced Risk of Benign Breast Diseases

20 March 2023

95

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Oestrogen and androgen receptors in breast cancer and response to endocrine therapy

20 March 2023

99

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Interaction of Δ5-Androstene-3β,17β-diol with Estradiol and Dihydrotestosterone Receptors in Human Myometrial and Mammary Cancer Tissue1

20 March 2023

101

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Androgen production and conversion to estrogens in normal postmenopausal women and in selected breast cancer patients

20 March 2023

102

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Regression of Spontaneous Mammary Tumors in Rats by Ergot Drugs

20 March 2023

103

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Estriol concentrations in plasma of normal, non-pregnant women

20 March 2023

105

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Effects of induced hyperthyroidism on steroid metabolism in man.

20 March 2023

106

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Inadequate corpus luteum function: a pathophysiological interpretation of human breast cancer epidemiology

20 March 2023

107

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Hormonal characteristics of the human menstrual cycle throughout reproductive life

20 March 2023

108

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

The Menopausal Transition: Analysis of LH, FSH, Estradiol, and Progesterone Concentrations During Menstrual Cycles of Older Women

20 March 2023

109

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Association of Exogenous Estrogen and Endometrial Carcinoma

20 March 2023

112

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Breast cancer and hypothyroidism

20 March 2023

113

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Oestrogen excretion of patients with breast cancer.

20 March 2023

114

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

MAMMARY TUMOR INDUCTION BY ESTROGEN OR ANTERIOR PITUITARY HORMONES IN OVARIECTOMIZED RATS GIVEN 7, 12-DIMETHYL-1, 2-BENZANTHRACENE

20 March 2023

115

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Post-menopausal estrogen production, with special reference to patients with mammary carcinoma

20 March 2023

116

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Urinary steroid assays and response to endocrine ablation

20 March 2023

117

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

20 March 2023

118

34

758

Turkington

1974

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Oral contraceptives and breast cancer. Progress report of an epidemiological study

20 March 2023

121

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Testosterone levels in the plasma of normal women and patients with benign breast disease or with breast cancer

20 March 2023

124

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Plasma prolactin and breast cancer.

20 March 2023

126

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

A study of the epidemiology of cancer of the breast

20 March 2023

127

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Increased Risk of Endometrial Carcinoma among Users of Conjugated Estrogens

20 March 2023

128

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

Decreased Conversion of Androgens to Normal 17-Ketosteroid Metabolites: A Nonspecific Consequence of Illness

20 March 2023

129

1 reference

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

https://api.crossref.org/works/10.1002/1097-0142(197706)39:6%3C2716::AID-CNCR2820390659%3E3.0.CO;2-3

20 March 2023

Identifiers

10.1002/1097-0142(197706)39:6<2716::AID-CNCR2820390659>3.0.CO;2-3

1 reference

13 September 2017

1 reference